Stem Cell Transplants for Early MS: Who Benefits Most? : vim

Researchers are exploring HSCT as a rescue therapy in early-stage MS. But there's no consensus on best practices.

Related Keywords

London , City Of , United Kingdom , Milan , Lombardia , Italy , Antonio Scalfari , Richard Nicholas , Imperial College London , Imperial College Healthcare , University Of Bergen Norway , Multiple Sclerosis Ms , Multiple Sclerosis , Us , Transplantation Stem Cell , Ransplantation Hematopoietic Stem Cell , Hematopoietic Stem Cell Transplantation , Stem Cell Transplantation , Stem Cell Therapy , Herapy Stem Cell , Transplantation , Transplant , Monoclonal Antibody , Etuximab , Ituximab , Relapsing Remitting Multiple Sclerosis , Arms , Ultiple Sclerosis Relapsing Remitting , Clinical Researc ,